Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Clinical trial NCT07214532 · RECRUITING

Trial details

NCT number: NCT07214532
Sponsor: Natera, Inc.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Neoplasms Carcinoma, Ductal, Breast Receptors, Estrogen (for ER-positive Requirement)

Start date: 2026-05-08
Primary completion: 2037-11-15
Enrollment: 725

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.